Cargando…
Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
BACKGROUND: To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. METHODS: Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072954/ https://www.ncbi.nlm.nih.gov/pubmed/17877793 http://dx.doi.org/10.1186/1748-717X-2-35 |
_version_ | 1782137809998446592 |
---|---|
author | Serre, Antoine Idri, Katia Fenoglietto, Pascal Ailleres, Norbert Santoro, Lore Lemanski, Claire Garrel, Renaud Makeieff, Marc Allaw, Ali Dubois, Jean-Bernard Azria, David |
author_facet | Serre, Antoine Idri, Katia Fenoglietto, Pascal Ailleres, Norbert Santoro, Lore Lemanski, Claire Garrel, Renaud Makeieff, Marc Allaw, Ali Dubois, Jean-Bernard Azria, David |
author_sort | Serre, Antoine |
collection | PubMed |
description | BACKGROUND: To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. METHODS: Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF treatment. The maximum point doses (D max) obtained for the different optic pathway structures (OPS) should differ no more than 3% from those achieved with the NCF IMRT plan. The distribution of the dose in the target volume and in the critical structures was compared between the two techniques, as well as the Conformity (CI) and the Homogeneity Indexes (HI) in the target volume. RESULTS: We noted no difference between the two techniques in the OPS for the D1, D2, and D5%, in the inner ear and controlateral lens for the average Dmax, in the temporo-mandibular joints for the average mean dose, in the cord and brainstem for the average D1%. The dose-volume histograms were slightly better with the NCF treatment plan for the planning target volume (PTV) with a marginally better HI but no impact on CI. We found a great improvement in the PTV coverage with the CF treatment plan for two patients with T4 tumors. CONCLUSION: IMRT is one of the treatment options for ethmoid cancer. The PTV coverage is optimal without compromising the protection of the OPS. The impact of non coplanar versus coplanar set up is very slight. |
format | Text |
id | pubmed-2072954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20729542007-11-10 Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer Serre, Antoine Idri, Katia Fenoglietto, Pascal Ailleres, Norbert Santoro, Lore Lemanski, Claire Garrel, Renaud Makeieff, Marc Allaw, Ali Dubois, Jean-Bernard Azria, David Radiat Oncol Research BACKGROUND: To compare non coplanar field (NCF) with coplanar field (CF) -intensity-modulated radiotherapy (IMRT) planning for ethmoid cancer. METHODS: Seven patients treated with NCF IMRT for ethmoid cancer were studied. A CF IMRT optimization was prepared with the same constraints as for the NCF treatment. The maximum point doses (D max) obtained for the different optic pathway structures (OPS) should differ no more than 3% from those achieved with the NCF IMRT plan. The distribution of the dose in the target volume and in the critical structures was compared between the two techniques, as well as the Conformity (CI) and the Homogeneity Indexes (HI) in the target volume. RESULTS: We noted no difference between the two techniques in the OPS for the D1, D2, and D5%, in the inner ear and controlateral lens for the average Dmax, in the temporo-mandibular joints for the average mean dose, in the cord and brainstem for the average D1%. The dose-volume histograms were slightly better with the NCF treatment plan for the planning target volume (PTV) with a marginally better HI but no impact on CI. We found a great improvement in the PTV coverage with the CF treatment plan for two patients with T4 tumors. CONCLUSION: IMRT is one of the treatment options for ethmoid cancer. The PTV coverage is optimal without compromising the protection of the OPS. The impact of non coplanar versus coplanar set up is very slight. BioMed Central 2007-09-18 /pmc/articles/PMC2072954/ /pubmed/17877793 http://dx.doi.org/10.1186/1748-717X-2-35 Text en Copyright © 2007 Serre et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Serre, Antoine Idri, Katia Fenoglietto, Pascal Ailleres, Norbert Santoro, Lore Lemanski, Claire Garrel, Renaud Makeieff, Marc Allaw, Ali Dubois, Jean-Bernard Azria, David Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
title | Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
title_full | Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
title_fullStr | Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
title_full_unstemmed | Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
title_short | Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
title_sort | dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2072954/ https://www.ncbi.nlm.nih.gov/pubmed/17877793 http://dx.doi.org/10.1186/1748-717X-2-35 |
work_keys_str_mv | AT serreantoine dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT idrikatia dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT fenogliettopascal dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT ailleresnorbert dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT santorolore dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT lemanskiclaire dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT garrelrenaud dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT makeieffmarc dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT allawali dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT duboisjeanbernard dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer AT azriadavid dosimetriccomparisonbetweencoplanarandnoncoplanarfieldradiotherapyforethmoidsinuscancer |